Literature DB >> 28817194

Prediction and prognosis of ventricular tachycardia recurrence after catheter ablation with remote magnetic navigation for electrical storm in patients with ischemic cardiomyopathy.

Qi Jin1,2, Peter Karl Jacobsen1, Steen Pehrson1, Xu Chen1.   

Abstract

BACKGROUND: Ventricular tachycardia (VT) recurrence after catheter ablation for electrical storm is commonly seen in patients with ischemic cardiomyopathy (ICM). HYPOTHESIS: We hypothesized that VT recurrence can be predicted and be related to the all-cause death after VT storm ablation guided by remote magnetic navigation (RMN) in patients with ICM.
METHODS: A total of 54 ICM patients (87% male; mean age, 65 ± 7.1 years) presenting with VT storm undergoing acute ablation using RMN were enrolled. Acute complete ablation success was defined as noninducibility of any sustained monomorphic VT at the end of the procedure. Early VT recurrence was defined as the occurrence of sustained VT within 1 month after the first ablation.
RESULTS: After a mean follow-up of 17.1 months, 27 patients (50%) had freedom from VT recurrence. Sustained VT recurred in 12 patients (22%) within 1 month following the first ablation. In univariate analysis, VT recurrence was associated with incomplete procedural success (hazard ratio [HR]: 6.25, 95% confidence interval [CI]: 1.20-32.47, P = 0.029), lack of amiodarone usage before ablation (HR: 4.71, 95% CI: 1.12-19.7, P = 0.034), and a longer procedural time (HR: 1.023, 95% CI: 1.00-1.05, P = 0.05). The mortality of patients with early VT recurrence was higher than that of patients without recurrence (P < 0.01).
CONCLUSIONS: Inducibility of any VT at the end of procedure for VT storm guided by RMN is the strongest predictor of VT recurrence. ICM patients who have early recurrences after VT storm ablation are at high risk of all-cause death.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Electrical Storm; Remote Magnetic Navigation; Ventricular Tachycardia

Mesh:

Year:  2017        PMID: 28817194      PMCID: PMC6490313          DOI: 10.1002/clc.22773

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  25 in total

1.  Catheter ablation of scar-related ventricular tachycardia in patients with electrical storm using remote magnetic catheter navigation.

Authors:  Arash Arya; Charlote Eitel; Andreas Bollmann; Ulrike Wetzel; Phillipp Sommer; Thomas Gaspar; Daniella Husser; Christopher Piorkowski; Gerhard Hindricks
Journal:  Pacing Clin Electrophysiol       Date:  2010-08-17       Impact factor: 1.976

2.  Long-term efficacy of single procedure remote magnetic catheter navigation for ablation of ischemic ventricular tachycardia: a retrospective study.

Authors:  Borislav Dinov; Robert Schönbauer; Agnieska Wojdyla-Hordynska; Frieder Braunschweig; Sergio Richter; David Altmann; Philipp Sommer; Thomas Gaspar; Andreas Bollmann; Ulrike Wetzel; Sascha Rolf; Christopher Piorkowski; Gerhard Hindricks; Arash Arya
Journal:  J Cardiovasc Electrophysiol       Date:  2012-02-07

3.  Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial.

Authors:  Stefan H Hohnloser; Hussein R Al-Khalidi; Craig M Pratt; Jose M Brum; Daljit S Tatla; Patrick Tchou; Paul Dorian
Journal:  Eur Heart J       Date:  2006-10-18       Impact factor: 29.983

4.  Catheter ablation of ventricular tachycardias using remote magnetic navigation: a consecutive case-control study.

Authors:  Tamas Szili-Torok; Bruno Schwagten; Ferdi Akca; Tamas Bauernfeind; Lara Dabiri Abkenari; David Haitsma; Yves Van Belle; Natasja D E Groot; Luc Jordaens
Journal:  J Cardiovasc Electrophysiol       Date:  2012-05-03

Review 5.  Catheter ablation of ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy: where are we today? A clinical review.

Authors:  Erik Wissner; William G Stevenson; Karl-Heinz Kuck
Journal:  Eur Heart J       Date:  2012-03-11       Impact factor: 29.983

6.  Prevalence and predictors of electrical storm in patients with implantable cardioverter-defibrillator.

Authors:  Arash Arya; Majid Haghjoo; Mohammad Reza Dehghani; Amir Farjam Fazelifar; Mohammad-Hosein Nikoo; Ataollah Bagherzadeh; Mohammad Ali Sadr-Ameli
Journal:  Am J Cardiol       Date:  2006-02-01       Impact factor: 2.778

7.  Remote magnetic navigation to guide endocardial and epicardial catheter mapping of scar-related ventricular tachycardia.

Authors:  Arash Aryana; Andre d'Avila; E Kevin Heist; Theofanie Mela; Jagmeet P Singh; Jeremy N Ruskin; Vivek Y Reddy
Journal:  Circulation       Date:  2007-02-12       Impact factor: 29.690

8.  Successful catheter ablation of electrical storm after myocardial infarction.

Authors:  Dietmar Bänsch; Feifan Oyang; Matthias Antz; Thomas Arentz; Reinhold Weber; Jesus E Val-Mejias; Sabine Ernst; Karl-Heinz Kuck
Journal:  Circulation       Date:  2003-12-08       Impact factor: 29.690

9.  Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.

Authors:  Corrado Carbucicchio; Matteo Santamaria; Nicola Trevisi; Giuseppe Maccabelli; Francesco Giraldi; Gaetano Fassini; Stefania Riva; Massimo Moltrasio; Manuela Cireddu; Fabrizio Veglia; Paolo Della Bella
Journal:  Circulation       Date:  2008-01-02       Impact factor: 29.690

10.  Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.

Authors:  Karl-Heinz Kuck; Anselm Schaumann; Lars Eckardt; Stephan Willems; Rodolfo Ventura; Etienne Delacrétaz; Heinz-Friedrich Pitschner; Josef Kautzner; Burghard Schumacher; Peter S Hansen
Journal:  Lancet       Date:  2010-01-02       Impact factor: 79.321

View more
  1 in total

1.  Pre-procedural image-guided versus non-image-guided ventricular tachycardia ablation-a review.

Authors:  A A Hendriks; Z Kis; M Glisic; W M Bramer; T Szili-Torok
Journal:  Neth Heart J       Date:  2020-11       Impact factor: 2.380

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.